SBIR/STTR Research Award

ANTIGEN-ANTIBODY COMPLEX FORMATION WHEN COUPLED WITH MARKER TECHNIQUES CONSTITUTE AS IMPORTANT AREA OF RESEARCH AND CLINICAL RESEARCH, TECHNIQUES OF COVALENTLY BINDING THESE IMMUNO-MACRO-MOLECULES TO DESIRED MARKERS BY IMPROVED PROCEDURES IS THE OBJECT

Award identifier 23da92d1edc03abb1693624c3d2a45838cdcc0d4b66b1cd9791a542035775f1fAwarding agency National Science Foundation

Award amount

$40,000

Program and phase

SBIR · Phase I

Award year

1985

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
National Science Foundation
Branch
Not reported
Recipient company
Polysciences Inc
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

ANTIGEN-ANTIBODY COMPLEX FORMATION WHEN COUPLED WITH MARKER TECHNIQUES CONSTITUTE AS IMPORTANT AREA OF RESEARCH AND CLINICAL RESEARCH, TECHNIQUES OF COVALENTLY BINDING THESE IMMUNO-MACRO-MOLECULES TO DESIRED MARKERS BY IMPROVED PROCEDURES IS THE OBJECT OF THIS STUDY. TO DETECT LOW LEVELS OF ANTIGENIC BEHAVIOR BY MONOCLONAL ANTIBODIES RAPIDLY, A NEW PREACTIVATED LATEX MICROPARTICLE SYSTEM WILL BE SYNTHESIZED TO ENHANCE THE EASE OF TAGGING SUCH ANTIGENS WITH ANTIBODIES. THE MICROPARTICLES WILL BE PREACTIVATED WITH N-HYDROXYSUCCINIMIDE ESTER UNITE AND LYOPHILIZED TO PREVENT HYDROLYTIC DEGRADATION ON STORAGE. BY SELECTING APPROPRIATE MONOMERS, HIGHLY CROSS-LINKED MICROPARTICLES OF HIGH POLARITY WILL BE FORMED WHICH REACT COVALENTLY WITH PROTEIN. HIGH DENSITY OF THE NEW LATEX PARTICLES WILL PERMIT EASY SEPARATION FROM SERUM. THEIR HIGH POLARITY WILLREDUCE OR ELIMINATE NON-SPECIFIC BONDING OF ANTIGENS. THESEPARTICLES WILL BIND TO MONOCLONAL ENTIBODIES WITHOUT FURTHERACTIVATION. BECAUSE OF THEIR HIGH DENSITY AND FLUORESCENCE OF THE LATEX TAG, THE MICROPARTICLE-ANTIBODY WILL PERMIT DETECTION OF LOW CONCENTRATIONS OF ANTIGENS BY FLOW CYTOMETRY OF AGGLUTINATION PROCEDURES. THE PRE-ACTIVATED NATURE OF MICROPARTICLES SHOULD GREATLY REDUCE PROCESSING TIME. IN PHASE I, THE FEASIBILITY OF PREPARING TECHNOLOGICALLY NOVEL LYOPHILIZED, PRE-ACTIVATED HIGH DENSITY LATICES AND THE SUITABILITY OF USING THESE MATERIALSFOR LOW-LEVEL ANTIGEN DETECTION WILL BE STUDIES. PHASE II WILL DEAL WITH OPTIMIZATION OF LATEX COMPOSITIONS OF PARTICLE SIZES AND OF VOLUME PRODUCTION OF LATICES. COMMERCIALLY, SUCH MATERIALS WILL FIND APPLICATION IN THE DETECTION OF THE ANTIGENIC ACTIVITY OF HEMATOLOGIC COMPONENTS OR HEMATOPOIETIC HAROMNES WITH APPROPRIATE ANTIBODIES.

Technology keywords

Not reported

Agency intelligence

National Science Foundation

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.